Literature DB >> 20804475

Endorectal magnetic resonance imaging has limited clinical ability to preoperatively predict pT3 prostate cancer.

Jonathan S Brajtbord1, Hugh J Lavery, Fatima Nabizada-Pace, Prathibha Senaratne, David B Samadi.   

Abstract

OBJECTIVE: • To assess the clinical value of preoperative knowledge of the presence of extracapsular extension (ECE) or seminal vesicle invasion (SVI) in the planning for prostatectomy.
MATERIALS AND METHODS: • An institutional database of 1161 robotic-assisted laparoscopic prostatectomies (RALP) performed by a single surgeon (D.B.S.) was queried for those who underwent endorectal coil magnetic resonance imaging (erMRI) before robotic-assisted laparoscopic prostatectomy. • erMRI reports were dichotomized into positive or negative and compared with the final histopathology. The erMRIs performed at academic centres were compared with those performed in non-academic settings. • A sub-group of high-risk patients was also analyzed for erMRI accuracy.
RESULTS: • The 179 patients who underwent erMRI had significantly worse disease compared to the 982 patients without imaging. Of the 110 patients with histopathologically organ-confined disease, 81 (74%) were correctly diagnosed as such on erMRI, whereas 29 (26%) were felt to have cT3 disease and constituted false-positives. Among the 69 patients with pT3 disease, erMRI correctly predicted 30 (43%), whereas 39 (57%) were incorrectly considered organ-confined. • The overall sensitivity and specificity for diagnosing pT3 disease was 43% and 73%. • When stratified by pT3a and pT3b, the sensitivity and specificity of erMRI to accurately diagnose ECE is 33% and 81%, respectively. In evaluating SVI, erMRI has a sensitivity and specificity of 33% and 89%, respectively. The positive predictive value of erMRI to assess for ECE and SVI is 50% in both, with a negative predictive value of 61% and 63%, respectively. • erMRIs performed at academic centres compared to non-academic locations demonstrated similar rates of sensitivity at 67% vs 77% and specificity at 39% vs 54%, respectively (P = 0.33).
CONCLUSIONS: • In the setting of the present study, which was designed to be more reflective of current practice patterns in the USA, erMRI has limited clinical value in preoperatively detecting ECE and SVI. • The accuracy of detecting T3 disease did not improve in academic centres or in high-risk patients.
© 2010 THE AUTHORS. JOURNAL COMPILATION © 2010 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2010        PMID: 20804475     DOI: 10.1111/j.1464-410X.2010.09599.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  18 in total

1.  Prediction of prostate cancer extracapsular extension with high spatial resolution dynamic contrast-enhanced 3-T MRI.

Authors:  B Nicolas Bloch; Elizabeth M Genega; Daniel N Costa; Ivan Pedrosa; Martin P Smith; Herbert Y Kressel; Long Ngo; Martin G Sanda; William C Dewolf; Neil M Rofsky
Journal:  Eur Radiol       Date:  2012-06-03       Impact factor: 5.315

2.  Preoperative mp-MRI of the prostate provides little information about staging of prostate carcinoma in daily clinical practice.

Authors:  Andrea Billing; Alexander Buchner; Christian Stief; Alexander Roosen
Journal:  World J Urol       Date:  2014-11-29       Impact factor: 4.226

3.  Utility of preoperative 3 Tesla pelvic phased-array multiparametric magnetic resonance imaging in prediction of extracapsular extension and seminal vesicle invasion of prostate cancer and its impact on surgical margin status: Experience at a Canadian academic tertiary care centre.

Authors:  Taehyoung Lee; Jen Hoogenes; Ian Wright; Edward D Matsumoto; Bobby Shayegan
Journal:  Can Urol Assoc J       Date:  2017-05-09       Impact factor: 1.862

4.  Oncologic outcomes after minimally invasive radical prostatectomy in patients with seminal vesicle invasion (pT3b) without adjuvant therapy.

Authors:  Aurélien Forgues; François Rozet; François Audenet; Adil Ouzzane; Rafaël Sanchez-Salas; Eric Barret; Marc Galiano; Dominique Prapotnich; Xavier Cathelineau
Journal:  World J Urol       Date:  2013-07-24       Impact factor: 4.226

5.  Integration of MRI to clinical nomogram for predicting pathological stage before radical prostatectomy.

Authors:  Cedric Lebacle; Françoise Roudot-Thoraval; Anissa Moktefi; Mohamed Bouanane; Alexandre De La Taille; Laurent Salomon
Journal:  World J Urol       Date:  2016-12-19       Impact factor: 4.226

6.  The predictability of T3 disease in staging MRI following prostate biopsy decreases in patients with high initial PSA and Gleason score.

Authors:  Young Hwii Ko; Deuk Jae Sung; Sung Gu Kang; Seok Ho Kang; Jeong Gu Lee; Je Jong Kim; Jun Cheon
Journal:  Asian J Androl       Date:  2011-03-07       Impact factor: 3.285

7.  Can 3T multiparametric magnetic resonance imaging accurately detect prostate cancer extracapsular extension?

Authors:  Yannick Cerantola; Massimo Valerio; Aida Kawkabani Marchini; Jean-Yves Meuwly; Patrice Jichlinski
Journal:  Can Urol Assoc J       Date:  2013 Nov-Dec       Impact factor: 1.862

Review 8.  Updated trends in imaging use in men diagnosed with prostate cancer.

Authors:  S P Porten; A Smith; A Y Odisho; M S Litwin; C S Saigal; P R Carroll; M R Cooperberg
Journal:  Prostate Cancer Prostatic Dis       Date:  2014-05-13       Impact factor: 5.554

9.  Prostate cancer magnetic resonance imaging (MRI): multidisciplinary standpoint.

Authors:  Liang Li; Liang Wang; Zhaoyan Feng; Zhiquan Hu; Guoping Wang; Xianglin Yuan; He Wang; Daoyu Hu
Journal:  Quant Imaging Med Surg       Date:  2013-04

10.  The accuracy of magnetic resonance imaging in prostate cancer staging: a single-institution experience.

Authors:  S F Oon; S P Power; J S Kelly; V McDermott; P Ryan; P C Ryan
Journal:  Ir J Med Sci       Date:  2014-04-06       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.